Literature DB >> 7474090

Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein.

S R Kyöstiö1, R S Wonderling, R A Owens.   

Abstract

Transcript levels from the P5 promoter of adeno-associated virus type 2 (AAV) are negatively regulated by the AAV Rep78 and Rep68 proteins in the absence of helper virus. We have identified a Rep-responsive negative cis element of the P5 promoter between the P5 TATA box and transcription start site by using 5' and 3' deletions of the P5 promoter fused to the chloramphenicol acetyltransferase gene. This element contains four imperfect GAGC repeats similar to the Rep recognition sequences (RRSs) in the AAV inverted terminal repeats and in the AAV preferred integration locus in chromosome 19. Band shift analyses showed that human 293 cell nuclear extracts containing Rep68 or Rep68/K340H, a putative nucleoside triphosphate (NTP)-binding-site mutant of Rep68, formed Rep-specific complexes with this P5 RRS DNA. Within the P5 RRS, mutation of a cytosine at position 273 in the AAV sequence to guanine abolished Rep68 binding to the DNA. A mutation in the P5 RRS within a full-length AAV genome, which abolished Rep binding, resulted in a 40 to 50% reduction in the ability of wild-type Rep68 to inhibit the accumulation of P5 transcripts in vivo. In contrast, the Rep68/K340H mutant was unable to down-regulate this mutated promoter. These results indicate that there are at least two mechanisms involved in the negative regulation of P5 transcript levels by Rep68; one involves Rep68 binding to the P5 RRS, and another requires the region of Rep68 containing the consensus NTP-binding motif. Furthermore, our studies of AAV genomes containing mutated RRS- and/or YY1-binding elements suggest that transcription factor YY1 binding to the transcription start site of P5 interferes with Rep68 repression of the P5 promoter.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474090      PMCID: PMC189590     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

2.  Mapping of the 5' termini of two adeno-associated virus 2 RNAs in the left half of the genome.

Authors:  E W Lusby; K I Berns
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

3.  Nucleotide sequence and organization of the adeno-associated virus 2 genome.

Authors:  A Srivastava; E W Lusby; K I Berns
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

4.  Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein.

Authors:  J P Trempe; B J Carter
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

5.  Factors that bind to adeno-associated virus terminal repeats.

Authors:  D S Im; N Muzyczka
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

6.  Replication of a human parvovirus nonsense mutant in mammalian cells containing an inducible amber suppressor.

Authors:  N Chejanovsky; B J Carter
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

7.  Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor.

Authors:  L S Chang; Y Shi; T Shenk
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

8.  Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein.

Authors:  A Beaton; P Palumbo; K I Berns
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Cellular transcription factor binds to adenovirus early region promoters and to a cyclic AMP response element.

Authors:  M A Leza; P Hearing
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more
  54 in total

1.  Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins.

Authors:  J Wu; M D Davis; R A Owens
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Adeno-associated virus RNAs appear in a temporal order and their splicing is stimulated during coinfection with adenovirus.

Authors:  M B Mouw; D J Pintel
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Mechanism of Rep-mediated adeno-associated virus origin nicking.

Authors:  J R Brister; N Muzyczka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  PKA/PrKX activity is a modulator of AAV/adenovirus interaction.

Authors:  Giovanni Di Pasquale; John A Chiorini
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

5.  Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins.

Authors:  J Hermanns; A Schulze; P Jansen-Db1urr; J A Kleinschmidt; R Schmidt; H zur Hausen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size.

Authors:  G E Tullis; T Shenk
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein.

Authors:  D Rinaudo; S Lamartina; G Roscilli; G Ciliberto; C Toniatti
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Structural Studies of AAV2 Rep68 Reveal a Partially Structured Linker and Compact Domain Conformation.

Authors:  Faik N Musayev; Francisco Zarate-Perez; Martino Bardelli; Clayton Bishop; Emil F Saniev; R Michael Linden; Els Henckaerts; Carlos R Escalante
Journal:  Biochemistry       Date:  2015-09-14       Impact factor: 3.162

9.  Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins.

Authors:  S Weger; A Wistuba; D Grimm; J A Kleinschmidt
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

10.  The cellular TATA binding protein is required for rep-dependent replication of a minimal adeno-associated virus type 2 p5 element.

Authors:  Achille François; Mickaël Guilbaud; Rafi Awedikian; Gilliane Chadeuf; Philippe Moullier; Anna Salvetti
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.